Amylyx Pharmaceuticals

PriceAmylyx Pharmaceuticals

AMLX

Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions.

Historical stock price chart and annual return over the past years

-81%

3 years

% Total

AMLX
-42%

3 years

Annual Return

AMLX